Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release for the Quarter end 30th September, 2018.05-11-2018
05-11-2018
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201502-11-2018
Outcome Of Board Meeting Held On 2Nd November, 2018.
Outcome of Board meeting held on 2nd November, 2018 pursuant to Regulation 33 and 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.02-11-2018
Closure of Trading Window
In accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the securities of the Company will be closed from Friday, 26th October, 2018 to Sunday, 4th November, 2018 (both days inclusive).25-10-2018
Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
AARTI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2018 ,inter alia, to consider and approve Audited Financial Results (Standalone & Consolidated) for the quarter and half year ended 30th September, 2018.25-10-2018
Certificate Under Regulation 40(9)For The Half Year Ended 30Th September, 2018.
Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended 30th September, 2018.23-10-2018
Shareholding for the Period Ended September 30, 2018
Aarti Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here20-10-2018
Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1331 Name of the Signatory :- Vibhav S. RanadeDesignation :- Company Secretary and Compliance Officer08-10-2018
Certificate Pursuant To Regulation 7(3) For The Period From 1St April, 2018 To 30Th September, 2018
Certificate pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half year ended 30th September, 201804-10-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release for June, 2018.14-08-2018